Build Healthcare Tech Intelligence Engine

Company Context

MedNova Health is a mid-sized healthcare technology company that sells care management and clinical workflow software to US provider organizations. The company generates $180M in annual revenue, serves 220 hospital systems and large physician groups, and has historically grown at 11% per year. Its core products are mature, but growth has slowed as buyers increasingly ask about AI-enabled documentation, remote monitoring, ambient scribing, and interoperability automation. The CEO wants a more systematic way to stay current with emerging technologies in healthcare so MedNova can make better product, partnership, and acquisition decisions.

Strategic Situation

You are the newly hired Director of Strategy. Today, MedNova tracks healthcare innovation informally through conferences, vendor demos, and customer conversations. As a result, the company often reacts late: it missed the first wave of ambient AI pilots and only recently began evaluating remote patient monitoring partnerships. The executive team is considering whether to build a formal technology intelligence function that continuously monitors emerging technologies, evaluates commercial relevance, and translates insights into product and go-to-market actions.

The question is not simply how to read industry news. The decision is whether MedNova should invest in a structured capability, what that capability should cover, and how it should influence strategic choices over the next 12 months.

Selected Data Points

Additional market signals:

• US digital health funding fell from $29B to $18B over the last two years, but AI-focused healthcare startups captured a growing share of funding.
• MedNova lost 3 competitive deals in the last 9 months where buyers cited stronger AI roadmaps from competitors.
• Product leadership estimates that 2 of the top 10 customer-requested features are tied directly to emerging technologies not currently on the roadmap.
• The company can support at most 2 major new strategic bets in the next 12 months without disrupting the core business.

Deliverables

1. Assess whether MedNova should build a formal healthcare technology intelligence capability now.
2. Define what sources, processes, and decision criteria the company should use to stay current with emerging technologies.
3. Prioritize which technology domains MedNova should monitor most closely over the next 12 months.
4. Recommend how insights should translate into product, partnership, and go-to-market decisions.
5. Propose a practical operating model, budget, and success metrics.

Constraints

• Total incremental budget cannot exceed $3M this year.
• Recommendations must show impact within 12 months.
• MedNova cannot pursue more than 2 major platform investments simultaneously.
• Any approach must work within a regulated healthcare environment with long enterprise sales cycles.